Logo image of PODD

INSULET CORP (PODD) Stock Price, Quote, News and Overview

NASDAQ:PODD - Nasdaq - US45784P1012 - Common Stock - Currency: USD

316.67  +6 (+1.93%)

Premarket: 317.02 +0.35 (+0.11%)

PODD Quote, Performance and Key Statistics

INSULET CORP

NASDAQ:PODD (5/12/2025, 8:00:01 PM)

Premarket: 317.02 +0.35 (+0.11%)

316.67

+6 (+1.93%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High318.86
52 Week Low170.67
Market Cap22.28B
Shares70.36M
Float69.93M
Yearly DividendN/A
Dividend YieldN/A
PE87.48
Fwd PE59.9
Earnings (Next)08-06 2025-08-06/amc
IPO05-15 2007-05-15


PODD short term performance overview.The bars show the price performance of PODD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15 20

PODD long term performance overview.The bars show the price performance of PODD in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60

The current stock price of PODD is 316.67 USD. In the past month the price increased by 24.68%. In the past year, price increased by 69.1%.

INSULET CORP / PODD Daily stock chart

PODD Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.61 228.91B
ISRG INTUITIVE SURGICAL INC 73.49 201.23B
BSX BOSTON SCIENTIFIC CORP 38.1 152.15B
SYK STRYKER CORP 30.97 148.13B
MDT MEDTRONIC PLC 16.07 110.05B
BDX BECTON DICKINSON AND CO 12.44 50.35B
EW EDWARDS LIFESCIENCES CORP 28.77 43.97B
IDXX IDEXX LABORATORIES INC 44.7 41.29B
RMD RESMED INC 27.28 36.31B
GEHC GE HEALTHCARE TECHNOLOGY 16.11 33.93B
DXCM DEXCOM INC 51.55 33.35B
PHG KONINKLIJKE PHILIPS NVR- NY 16.58 23.54B

About PODD

Company Profile

PODD logo image Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts and currently employs 3,900 full-time employees. The company went IPO on 2007-05-15. The company is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. The company also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.

Company Info

INSULET CORP

100 Nagog Park

Acton MASSACHUSETTS 01720 US

CEO: Shacey Petrovic

Employees: 3900

PODD Company Website

PODD Investor Relations

Phone: 19786007000

INSULET CORP / PODD FAQ

What is the stock price of INSULET CORP today?

The current stock price of PODD is 316.67 USD. The price increased by 1.93% in the last trading session.


What is the ticker symbol for INSULET CORP stock?

The exchange symbol of INSULET CORP is PODD and it is listed on the Nasdaq exchange.


On which exchange is PODD stock listed?

PODD stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for INSULET CORP stock?

31 analysts have analysed PODD and the average price target is 323.11 USD. This implies a price increase of 2.03% is expected in the next year compared to the current price of 316.67. Check the INSULET CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is INSULET CORP worth?

INSULET CORP (PODD) has a market capitalization of 22.28B USD. This makes PODD a Large Cap stock.


How many employees does INSULET CORP have?

INSULET CORP (PODD) currently has 3900 employees.


What are the support and resistance levels for INSULET CORP (PODD) stock?

INSULET CORP (PODD) has a support level at 260.47. Check the full technical report for a detailed analysis of PODD support and resistance levels.


Is INSULET CORP (PODD) expected to grow?

The Revenue of INSULET CORP (PODD) is expected to grow by 19.17% in the next year. Check the estimates tab for more information on the PODD EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy INSULET CORP (PODD) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does INSULET CORP (PODD) stock pay dividends?

PODD does not pay a dividend.


When does INSULET CORP (PODD) report earnings?

INSULET CORP (PODD) will report earnings on 2025-08-06, after the market close.


What is the Price/Earnings (PE) ratio of INSULET CORP (PODD)?

The PE ratio for INSULET CORP (PODD) is 87.48. This is based on the reported non-GAAP earnings per share of 3.62 and the current share price of 316.67 USD. Check the full fundamental report for a full analysis of the valuation metrics for PODD.


What is the Short Interest ratio of INSULET CORP (PODD) stock?

The outstanding short interest for INSULET CORP (PODD) is 3.18% of its float. Check the ownership tab for more information on the PODD short interest.


PODD Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to PODD. When comparing the yearly performance of all stocks, PODD is one of the better performing stocks in the market, outperforming 95.76% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

PODD Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to PODD. Both the health and profitability get an excellent rating, making PODD a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PODD Financial Highlights

Over the last trailing twelve months PODD reported a non-GAAP Earnings per Share(EPS) of 3.62. The EPS increased by 12.42% compared to the year before.


Industry RankSector Rank
PM (TTM) 20.19%
ROA 13.55%
ROE 34.52%
Debt/Equity 1.08
Chartmill High Growth Momentum
EPS Q2Q%39.73%
Sales Q2Q%28.82%
EPS 1Y (TTM)12.42%
Revenue 1Y (TTM)22.07%

PODD Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to PODD. The Buy consensus is the average rating of analysts ratings from 31 analysts.

For the next year, analysts expect an EPS growth of 29.11% and a revenue growth 19.17% for PODD


Ownership
Inst Owners102.12%
Ins Owners0.24%
Short Float %3.18%
Short Ratio2.47
Analysts
Analysts83.23
Price Target323.11 (2.03%)
EPS Next Y29.11%
Revenue Next Year19.17%